| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹525.14 Cr |
| Fresh Issue | ₹40.00 Cr |
| Offer for Sale | ₹485.14 Cr |
| Face Value | โน10 Per Equity Share |
| Price Band | โน177.00-186.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 544131 |
| NSE Code | GPTHEALTH |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | JM Financial Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 80 shares and in multiples thereof
Incorporated in 1989, GPT Healthcare Limited operates a chain of mid-sized, multi-specialty, full-service hospitals in Eastern India under the ILS Hospitals brand, providing integrated healthcare services focusing on secondary and tertiary care.
Based in Kolkata, West Bengal, the company offers a range of healthcare services in over 35 specialties and super-specialties, including internal medicine and diabetology, nephrology (including kidney transplant), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. It also offers integrated diagnostic services and pharmacies.
GPT Healthcare's hospitals are located in four cities, namely
As at June 30, 2023, the company operates four multidisciplinary hospitals with a total capacity of 561 beds, offering a comprehensive range of healthcare services in over 35 specialties and super-specialties.
As at June 30, 2023, the company had 1,855 employees, 85 full-time consultants, and 465 visiting consultants.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company from banks and financialinstitutions | 30.00 |
| 2 | General corporate purpose | 7.52 |
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 332.09 | 326.76 | 323.22 | 317.21 |
| Total Income | 206.70 | 366.73 | 342.40 | 248.86 |
| Profit After Tax | 23.49 | 39.01 | 41.66 | 21.09 |
| NET Worth | 171.43 | 164.14 | 156.96 | 132.68 |
| Reserves and Surplus | 92.75 | 85.46 | 78.28 | 75.96 |
| Total Borrowing | 55.57 | 64.67 | 95.52 | 122.93 |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | 23.59% |
| ROCE | 26.09% |
| Debt / Equity | 0.39% |
| RoNW | 23.77% |
| PAT Margin | 10.64% |
| Price to Book Value | 9.06 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 4.88 | 0.00 |
| P/E (x) | 38.1 | 32.49 |
| Promoter Holding | 67.34% | 65.57% |
| Market Cap | โน1526.22 Cr. | |